US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Avicel PH- 102 NF

Reason Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

DuPont Nutrition USA, Inc D-0350-2023
Class III · Low risk Terminated

Avicel PH- 101 NF

Reason Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

DuPont Nutrition USA, Inc D-0349-2023
Class III · Low risk Ongoing

Atropine Sulfate Ophthalmic Solution

Reason Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

Akorn, Inc. D-0265-2023
Class III · Low risk Terminated

Clobetasol propionate Cream USP

Reason Subpotent Drug: Low assay result observed during long-term stability testing.

Lupin Pharmaceuticals Inc. NDC 68180-956-03 D-0174-2023
Class III · Low risk Terminated

FentaNYL Citrate 2.5mg/50mL

Reason Short Fill: Underfilled units.

OurPharma LLC NDC 73013-1001-01 D-0172-2023
Class III · Low risk Terminated

Levofloxacin Tablets

Reason Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.

Macleods Pharma USA, INC NDC 33342-022-08 D-0162-2023
Class III · Low risk Terminated

Sinuva

Reason Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.

Intersect ENT, Inc. NDC 10599-003-01 D-0167-2023
Class III · Low risk Terminated

Prochlorperazine Maleate Tablets

Reason Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-113-06 D-0096-2023
Class III · Low risk Terminated

Timolol Maleate Ophthalmic Solution

Reason Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.

Apotex Corp. NDC 60505-1005-4 D-0093-2023
Class III · Low risk Terminated

Lacosamide Oral Solution

Reason Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content

Camber Pharmaceuticals, Inc NDC 31722-627-26 D-0094-2023
Class III · Low risk Terminated

Allergy Relief D

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 49032-273-20 D-0073-2023
Class III · Low risk Terminated

Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads

Reason Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.

Acella Pharmaceuticals, LLC NDC 42192-113-60 D-0074-2023
Class III · Low risk Terminated

Phenytoin Sodium Injection

Reason Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Acella Pharmaceuticals, LLC NDC 42192-614-05 D-0070-2023
Class III · Low risk Terminated

Phenytoin Sodium Injection

Reason Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Acella Pharmaceuticals, LLC NDC 42192-614-02 D-0069-2023
Class III · Low risk Terminated

Susvimo

Reason Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.

Genentech Inc NDC 50242-078-55 D-0025-2023
Class III · Low risk Terminated

Fyarro

Reason Failed Stability Specifications

Aadi Bioscience NDC 80803-153-50 D-0059-2023
Class III · Low risk Terminated

NDC 0363-6171-09 Walgreens Sinus Pressure

Reason Boxes mislabeled to read "Decongestant Free", but the product contains Phenylephrine HCI 5mg

LNK International, Inc. NDC 0363-6171-09 D-0014-2023
Class III · Low risk Ongoing

Tranexamic Acid Injection

Reason Presence of Particulate Matter: Piece of metal found in a vial

AuroMedics Pharma LLC NDC 55150-188-10 D-1551-2022
Class III · Low risk Terminated

oxyTOCIN 30 Units/500 mL

Reason Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).

QuVa Pharma, Inc. D-1544-2022
Class III · Low risk Terminated

Clonidine Hydrochloride Tablets

Reason Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,

Unichem Pharmaceuticals USA INC NDC 29300-137-01 D-1541-2022
Class III · Low risk Terminated

Xolegel

Reason Failed Viscosity specification: Slightly higher OOS results obtained for viscosity

Almirall, LLC NDC 16110-080-45 D-1549-2022
Class III · Low risk Completed

Phytonadione Injectable Emulsion USP

Reason Failed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.

Dr. Reddy's Laboratories, Inc. NDC 43598-405-16 D-0007-2023